Intermittent theta burst stimulation (iTBS) versus 10 Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) to alleviate treatment-resistant unipolar depression: A randomized controlled trial (THETA-DEP)
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Recently intermittent theta burst stimulation (iTBS) proved to be non-inferior to conventional repetitive transcranial magnetic stimulation (10 Hz rTMS) in unipolar depression after failure of one antidepressant trial, but to date no randomized control trial assessed the ability of iTBS to improve depression level and quality of life in more resistant features of depression with a long-term (6 month) follow-up in comparison to 10 Hz rTMS. OBJECTIVES/HYPOTHESIS: The aim of our study was to compare the efficacy of 10 Hz rTMS and iTBS in treatment-resistant unipolar depression on response rates (50% decrease of MADRS scores at one month from baseline) and change in quality of life during a 6-month follow-up. In addition, we investigated whether some clinical features at baseline were associated with the response in the different groups. METHOD: Sixty patients were randomized in a double-blind, controlled study at the University Hospital Center of Nantes, and received 20 sessions of either rTMS or iTBS applied to the left dorsolateral prefrontal cortex targeted by neuronavigation. Statistical analysis used Fischer's exact test and Chi-square test as appropriate, linear mixed model, and logistic regression (occurrence of depressive relapse and factors associated with the therapeutic response). RESULTS: Included patients showed in mean more than 3 antidepressants trials. Response rates were 36.7% and 33.3%, and remission rates were 18.5% and 14.8%, in the iTBS and 10 Hz rTMS groups respectively. Both groups showed a similar significant reduction in depression scores and quality of life improvement at 6 months. We did not find any clinical predictive factor of therapeutic response in this sample. CONCLUSION: Our study suggests the clinical interest of iTBS stimulation (which is more time saving and cost-effective as conventional rTMS) to provide long-lasting improvement of depression and quality of life in highly resistant unipolar depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McHorney, C. A., Ware, J. E., Rachel Lu, J. F., & Sherbourne, C. D. (1994) · Medical Care · doi:10.1097/00005650-199401000-00004 · Cited by 4,458
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 1×
“Even in cases of initial remission, the STAR * D study observed a relapse rate of 43% a year after treatment [3,4].”
A scale for the assessment of hedonic tone the Snaith-Hamilton pleasure scale
Snaith, R. P., Hamilton, M., Morley, S., Humayan, A., Hargreaves, D., & Trigwell, P. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.167.1.99 · Cited by 1,778
Cost of disorders of the brain in Europe 2010
Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.08.008 · Cited by 1,723
Diagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380 · cited 1×
“However, antidepressants remain insufficiently effective: 40% of patients do not respond to initial treatments, and 20% of depressions are resistant to pharmacological treatments [2].”
Blumberger, D. M., Vila-Rodriguez, F., Thorpe, K. E., Feffer, K., Noda, Y., Giacobbe, P., Knyahnytska, Y., Kennedy, S. H., Lam, R. W., Daskalakis, Z. J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30295-2 · Cited by 1,363 · cited 4×
“Although this was not a noninferiority study, the response and remission rates for both groups were similar, which is in line with Blumberger's findings of iTBS and 10 Hz rTMS equivalence [16].”
InfluentialStanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression
Cole, E. J., Stimpson, K. H., Bentzley, B. S., Gulser, M., Cherian, K., Tischler, C., Nejad, R., Pankow, H., Choi, E., Aaron, H., et al. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19070720 · Cited by 802
McClintock, S. M., Reti, I. M., Carpenter, L. L., McDonald, W. M., Dubin, M., Taylor, S. F., Cook, I. A., O’Reardon, J., Husain, M. M., Wall, C., et al. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16cs10905 · Cited by 693 · cited 1×
“In parallel, within the last decade, repetitive transcranial magnetic stimulation (rTMS) has assumed an increasingly important role in the depression treatment armamentarium [6,7].”
Berlim, M. T., van den Eynde, F., Tovar-Perdomo, S., & Daskalakis, Z. J. (2014) · Psychological Medicine · doi:10.1017/s0033291713000512 · Cited by 620 · cited 1×
“Response rates for rTMS vary, on average, from 40% to 60% [8,9].”
Ten years of theta burst stimulation in humans: Established knowledge, unknowns and prospects
Suppa, A., Huang, Y.-Z., Funke, K., Ridding, M. C., Cheeran, B., Di Lazzaro, V., Ziemann, U., & Rothwell, J. C. (2016) · Brain Stimulation · doi:10.1016/j.brs.2016.01.006 · Cited by 609 · cited 1×
“The very high frequency of TBS (50 Hz) mimics endogenous theta rhythms, promotes brain plasticity, induces long-term potentiation [19], and may recruit networks involved in depression physiopathology that oscillate at 50 Hz [20].”
Milev, R. V., Giacobbe, P., Kennedy, S. H., Blumberger, D. M., Daskalakis, Z. J., Downar, J., Modirrousta, M., Patry, S., Vila-Rodriguez, F., Lam, R. W., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716660033 · Cited by 586 · cited 1×
“Currently, the gold standard for treatment-resistant depression (TRD) remains electroconvulsive therapy (ECT), especially in the presence of life-threatening conditions, high suicidal risk, or depressionwith psychotic symptoms [5].”
Mutz, J., Vipulananthan, V., Carter, B., Hurlemann, R., Fu, C. H. Y., & Young, A. H. (2019) · BMJ · doi:10.1136/bmj.l1079 · Cited by 427 · cited 1×
“Recent meta-analyses show the superiority, when compared with placebo treatments, of several brain stimulation techniques: high-frequency rTMS (HF-rTMS) and intermittent theta-burst stimulation (iTBS) of the left dorsolateral prefrontal cortex (DLPFC), low-frequency rTMS of the right DLPFC, and sequential bilateral st…”
Avery, D. H., Holtzheimer, P. E., Fawaz, W., Russo, J., Neumaier, J., Dunner, D. L., Haynor, D. R., Claypoole, K. H., Wajdik, C., & Roy-Byrne, P. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.003 · Cited by 318
Integrative Psychobiological Approach to Psychiatric Assessment and Treatment
Cloninger, C. R., & Svrakic, D. M. (1997) · Psychiatry · doi:10.1080/00332747.1997.11024793 · Cited by 262
Dunner, D. L., Rush, A. J., Russell, J. M., Burke, M., Woodard, S., Wingard, P., & Allen, J. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0501 · Cited by 234 · cited 1×
“In contrast, medication adherence is estimated to be ~50% [50,51].”
High-dose spaced Theta-burst TMS as a rapid-acting antidepressant in highly refractory depression
Williams, N. R., Sudheimer, K. D., Bentzley, B. S., Pannu, J., Stimpson, K. H., Duvio, D., Cherian, K., Hawkins, J., Scherrer, K. H., Vyssoki, B., et al. (2018) · Brain · doi:10.1093/brain/awx379 · Cited by 215
Chevance, A., Ravaud, P., Tomlinson, A., Le Berre, C., Teufer, B., Touboul, S., Fried, E. I., Gartlehner, G., Cipriani, A., & Tran, V. T. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30191-7 · Cited by 193 · cited 1×
“Improvements in quality of life concerned most SF-36 domains, including mental health, but also physical, emotional, and social functioning, which patients prioritize [47].”
Early Identification and Intervention in Depressive Disorders: Towards a Clinical Staging Model
Hetrick, S. E., Parker, A. G., Hickie, I. B., Purcell, R., Yung, A. R., & McGorry, P. D. (2008) · Psychotherapy and Psychosomatics · doi:10.1159/000140085 · Cited by 186 · cited 1×
“Reneses et al. [55] have associated such scores with “ severe, persisting and unremitting illness as judged on symptoms, neurocognition and disability criteria ” , making reference to the Hetrick staging model [56].”
Accelerated theta burst stimulation for the treatment of depression: a randomised controlled trial
Chen, L., Thomas, E. H. X., Kaewpijit, P., Miljevic, A., Hughes, R., Hahn, L., Kato, Y., Gill, S., Clarke, P., Ng, F., et al. (2021) · Brain Stimulation · doi:10.1016/j.brs.2021.07.018 · Cited by 105 · cited 1×
“The selected intensity of 80% of RMT should not have hindered TBS ef fi cacy since a recent large study (n ¼ 300) found no difference in response between sub-and supra-threshold intensities (80% and 120%, respectively) for bilateral TBS in patients with TRD [61].”
Trevizol, A. P., Downar, J., Vila-Rodriguez, F., Thorpe, K. E., Daskalakis, Z. J., & Blumberger, D. M. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100349 · Cited by 70 · cited 1×
“The main clinical predictors of positive outcomes identified for iTBS and Left High Frequency rTMS in the Three-D Study were lower baseline depression scores [28,29], older age, lack of benzodiazepine use [28], fewer past treatment failures, lower baseline anxiety and current employment [29].”
Li, C.-T., Chen, M.-H., Juan, C.-H., Liu, R.-S., Lin, W.-C., Bai, Y.-M., & Su, T.-P. (2018) · Brain Stimulation · doi:10.1016/j.brs.2018.04.014 · Cited by 70
Intermittent theta burst stimulation (iTBS) ameliorates therapy-resistant depression: A case series
Holzer, M., & Padberg, F. (2010) · Brain Stimulation · doi:10.1016/j.brs.2009.10.004 · Cited by 55 · cited 1×
“At the time of study design (before the first large study published in 2018), we anticipated a response rate of 25% in the 10 Hz rTMS group [18] and 60% in the iTBS group [46], in light of pilot studies.”
Samalin, L., Rothärmel, M., Mekaoui, L., Gaudré-Wattinne, E., Codet, M.-A., Bouju, S., & Sauvaget, A. (2022) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2022.2030757 · Cited by 54
Self-citationIs accelerated, high-dose theta burst stimulation a panacea for treatment-resistant depression?
Caulfield, K. A. (2020) · Journal of Neurophysiology · doi:10.1152/jn.00537.2019 · Cited by 26
Staging of depressive disorders: Relevance of resistance to treatment and residual symptoms
Reneses, B., Aguera-Ortiz, L., Sevilla-Llewellyn-Jones, J., Carrillo, A., Argudo, I., Regatero, M. J., López-Micó, C., Fuentes, M., & Palomo, T. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.07.022 · Cited by 7 · cited 1×
“[55] have associated such scores with “severe, persisting and unremitting illness as judged on symptoms, neurocognition and disability criteria”, making reference to the Hetrick staging model [56].”
Cited by
McIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., et al. (2023) · World Psychiatry · doi:10.1002/wps.21120 · Cited by 836
Morriss, R., Briley, P. M., Webster, L., Abdelghani, M., Barber, S., Bates, P., Brookes, C., Hall, B., Ingram, L., Kurkar, M., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02764-z · Cited by 122
“Previous RCTs suggest that iTBS and rTMS may be equivalent in efficacy in TRD 9,40 .”
InfluentialTrapp, N. T., Purgianto, A., Taylor, J. J., Singh, M. K., Oberman, L. M., Mickey, B. J., Youssef, N. A., Solzbacher, D., Zebley, B., Cabrera, L. Y., et al. (2025) · Clinical Neurophysiology · doi:10.1016/j.clinph.2024.12.015 · Cited by 89
Liu, C., Li, L., Li, B., Liu, Z., Xing, W., Zhu, K., Jin, W., Lin, S., Tan, W., Ren, L., et al. (2024) · Neuromodulation: Technology at the Neural Interface · doi:10.1016/j.neurom.2023.08.009 · Cited by 17
Induction of plasticity and metaplasticity using noninvasive brain stimulation
Bhattacharya, A., Darmani, G., Udupa, K., Nankoo, J.-F., Ding, M. Y. R., & Chen, R. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.07.009 · Cited by 14
Metadata
- Authors
- Bulteau, S., Laurin, A., Pere, M., Fayet, G., Thomas-Ollivier, V., Deschamps, T., Auffray-Calvier, E., Bukowski, N., Vanelle, J.-M., Sébille, V., & Sauvaget, A.
- Venue
- Brain Stimulation
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 15
- Issue
- 3
- Pages
- 870-880
- ISSN
- 1876-4754 (ISSN-L)
- 1935-861X
- OpenAlex
- W4281256360
- Cited by
- 97
- References
- 25
- FWCI
- 5.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.